Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future
Eur J Clin Invest 2010; 40 (5): 451–464 Abstract Background Antiphospholipid syndrome
(APS) is a systemic autoimmune vascular disease characterized by recurrent thrombotic …
(APS) is a systemic autoimmune vascular disease characterized by recurrent thrombotic …
Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future
AA Mehdi, I Uthman, M Khamashta - European Journal of Clinical …, 2010 - infona.pl
Eur J Clin Invest 2010; 40 (5): 451–464 Abstract Background Antiphospholipid syndrome
(APS) is a systemic autoimmune vascular disease characterized by recurrent thrombotic …
(APS) is a systemic autoimmune vascular disease characterized by recurrent thrombotic …
Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future
AA Mehdi, I Uthman… - European journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Antiphospholipid syndrome (APS) is a systemic autoimmune vascular disease
characterized by recurrent thrombotic episodes and/or obstetric complications. Management …
characterized by recurrent thrombotic episodes and/or obstetric complications. Management …
[引用][C] Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future
AA MEHDI, I UTHMAN… - European journal of …, 2010 - pascal-francis.inist.fr
Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the
future CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
future CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
[引用][C] Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future
M AA - Eur J Clin Invest, 2010 - cir.nii.ac.jp
Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future
AA Mehdi, I Uthman, M Khamashta - European Journal of Clinical …, 2010 - kclpure.kcl.ac.uk
Abstract P> Background Antiphospholipid syndrome (APS) is a systemic autoimmune
vascular disease characterized by recurrent thrombotic episodes and/or obstetric …
vascular disease characterized by recurrent thrombotic episodes and/or obstetric …
Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future.
AA Mehdi, I Uthman, M Khamashta - European Journal of Clinical …, 2010 - europepmc.org
Background Antiphospholipid syndrome (APS) is a systemic autoimmune vascular disease
characterized by recurrent thrombotic episodes and/or obstetric complications. Management …
characterized by recurrent thrombotic episodes and/or obstetric complications. Management …
[PDF][PDF] Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future
AA Mehdi, I Uthman, M Khamashta - European Journal of Clinical …, 2010 - academia.edu
Background Antiphospholipid syndrome (APS) is a systemic autoimmune vascular disease
characterized by recurrent thrombotic episodes and⁄ or obstetric complications. Management …
characterized by recurrent thrombotic episodes and⁄ or obstetric complications. Management …
Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future.
AA Mehdi, I Uthman… - European Journal of …, 2010 - search.ebscohost.com
Abstract Eur J Clin Invest 2010; 40 (5): 451–464 Background Antiphospholipid syndrome
(APS) is a systemic autoimmune vascular disease characterized by recurrent thrombotic …
(APS) is a systemic autoimmune vascular disease characterized by recurrent thrombotic …